Takeda also named Global Top Employer for Fourth Year running
Mumbai, 25 January 2021 : Takeda India has been named a Top Employer in 2021 by Top Employers Institute. This is also the fourth year in a row Takeda has received the prestigious global Top Employer® status.Takeda also received four regional certifications for Asia Pacific, Europe, Latin America and Middle East.
Of the 38 Takeda local operating companies (LOCs) that were accredited this year, 24 are in Takeda’s Growth & Emerging Markets Business Unit, including India.
“We are delighted to be named as Top Employer in India. At Takeda, empowering our people to shine is of utmost importance as we firmly believe that this is key in helping them give their best in our commitment to meet the needs of patients in the emerging markets,” said Anoop Kamat, Head of HR.“Today’s challenging COVID-19 pandemic environment calls for a heightened people-centric focus. In providing support for our employees, embracing diversity, and fostering a culture of trust, we can help create better health for people and a brighter future for the world.”
Top Employers Institute CEO David Plink commented, “Takeda continues to show its dedication to its employees globally and locally, and we congratulate them for the fourth year in a row of global Top Employer certification.”
The Top Employers Institute program certifies organizations based on the participation and results of their HR Best Practices Survey. This survey covers 6 HR domains consisting of 20 people-centric topics such as Career Development, Culture, Diversity & Inclusion, Learning, Sustainability, Values, Well-being and Work Environment. Established 30 years ago, the Institute has certified more than 1,600 Top Employers across five continents.
Takeda surpassed the requirements of Top Employers Institute, excelling in the areas of Values, Ethics & Integrity, Organizational Change, Leadership, Sustainability, Performance Management, and Engagement. The 38 LOCs that received accreditation in the geographic areas as defined by the Institute are :
- Africa: Algeria
- Asia Pacific: Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand
- Europe: Austria, Finland, France, Germany, Ireland, Italy, Kazakhstan, Poland, Portugal, Russia, Spain, Switzerland, Turkey, UK, and Ukraine
- Latin America: Argentina, Brazil, Colombia, Ecuador, Mexico and Peru
- Middle East: Israel, Saudi Arabia, and United Arab Emirates
- North America: United State
To learn more about Top Employers Institute and the Top Employers certification please visit: www.top-employers.com.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.For more information, visit https://www.takeda.com.
About Takeda’s Growth & Emerging Markets Business Unit
Led from its Regional offices in Singapore, Takeda’s Growth & Emerging Markets Business Unit (GEM BU), is committed to addressing patient unmet medical needs wherever it operates. This includes those parts of the world with some of the heaviest healthcare burdens.
The GEM BU is primarily focused on delivering medical innovation to patients in the areas of Oncology, Gastroenterology, Plasma Derived Therapies, and Rare Diseases, via a direct presence that spans almost 50 geographies including Brazil, China and Russia. These three countries, in addition to three Area operations* with Area hubs in South America, the Middle East, and Asia Pacific, are of particular focus as part of the Region’s ambition to deliver sustainable, profitable growth via our commercial activities, and to increasing the number of patient lives positively impacted via the Company’s commitments to increase Access to Medicines.
GEM BU also aspires to be viewed as ‘Best-in-Class’ in the eyes of patients, customers and its own employees. Currently within the Region, a total of 24 local Takeda operations have been externally recognized as a ‘top employer’ by the Top Employer Institute.
*ICMEA - India, CIS, the Middle East & Africa led from Dubai, UAE
SAM - South Cone, Andean & Mexico led from Buenos Aires, Argentina
APAC - Asia Pacific led from Singapore
About Takeda India
Takeda India is part of Takeda Pharmaceutical Company Limited's group of companies. Locally, the company currently focuses on the areas of Rare Diseases, including Hemophilia and Lysosomal Storage Disorders and plasma-derived therapies. Takeda also has presence in Sri Lanka while Nepal and Bangladesh are served on a demand basis.
No comments:
Post a Comment